Funds holding CLOVER BIOPHARMACEUTICALS LTD
ISIN KYG2280A1076 · Cayman Islands
- Fund holders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 2.2M $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Series Emerging Markets Opportunities Fund Fidelity Investment Trust | 5,077,500 | 1.9M $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Emerging Markets Equity Central Fund Fidelity Central Investment Portfolios LLC | 604,770 | 208.5K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Emerging Markets Equity Central Fund Fidelity Central Investment Portfolios LLC | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Emerging Markets Opportunities Fund Fidelity Investment Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 2 | 0 | 5,682,270 | +1.2 % |
| 2026Q1 | 2 | +1 | 5,614,770 | +80.2 % |
| 2025Q4 | 1 | 0 | 3,116,000 | +7,690.0 % |
| 2024Q2 | 1 | 0 | 40,000 | -1.2 % |
| 2024Q1 | 1 | -1 | 40,500 | -83.0 % |
| 2023Q4 | 2 | 238,500 |
Cite this page
Titelia. "Funds holding CLOVER BIOPHARMACEUTICALS LTD". https://titelia.com/en/stocks/clover-biopharmaceuticals-ltd-KYG2280A1076